Skip to main content
SpringerLink
Log in

Clomerular and urinary heparan sulphate in congenital nephrotic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Studies using cationic probes have suggested that a reduction in glomerular anionic sites, composed principally of the glycosaminoglycan heparan sulphate, is responsible for the abnormal glomerular permeability in the congenital nephrotic syndrome (CNS). We therefore analysed the glycosaminoglycan content of the glomerular basement membrane (GBM) from an infant who died of CNS and from an infant who died of unrelated causes. We also measured the urinary excretion of glycosaminoglycans in children with nephrotic syndrome, both congenital and acquired, and in healthy children. Heparan sulphate constituted 59% of the glycosaminoglycan content of the GBM in the normal infant, the other principal glycosaminoglycan being chondroitin sulphate. In the GBM from the infant with CNS the heparan sulphate was greatly reduced, constituting only 3% of total glycosaminoglycans. The urinary excretion of heparan sulphate was significantly increased in CNS (expressed both in relation to creatinine and to chondroitin sulphate) compared with normal children and to those with acquired nephrotic syndrome. Diminished GBM content of heparan sulphate may be responsible for the abnormal glomerular permeability in CNS and may be a consequence of defective incorporation of heparan sulphate into the GBM with subsequent loss into the urine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Deen WM, Myers BD, Brenner BM (1982) The glomerular barrier to macromolecules; theoretical and experimental considerations. In: Brenner BM, Stein JH (eds) Contemporary issues in nephrology, vol 9. Churchill-Livingstone, New York, pp 1–29

    Google Scholar 

  2. Rennke HG, Venkatachalam MA (1977) Glomerular permeability: in vivo tracer studies with polyanionic and polycationic ferritins. Kidney Int 11: 44–53

    PubMed  Google Scholar 

  3. Kanwar YS (1984) Biophysiology of glomerular filtration and proteinuria. Lab Invest 51: 7–21

    PubMed  Google Scholar 

  4. Brenner BM, Hostetter TH, Humes MD (1978) Molecular basis of proteinuria of glomerular origin. N Engl J Med 278: 826–833

    Google Scholar 

  5. Michael AF, Blau E, Vernier RL (1970) Glomerular polyanion: alteration in aminonucleoside nephrosis. Lab Invest 23: 649–657

    PubMed  Google Scholar 

  6. Blau EB, Haas JE (1973) Glomerular sialic acid and proteinuria in human renal disease. Lab Invest 28: 477–481

    PubMed  Google Scholar 

  7. Kanwar YS, Farquhar MG (1979) Isolation of glycosaminoglycans (heparan sulphate) from glomerular basement membranes. Proc Natl Acad Sci USA 76: 4493–4497

    PubMed  Google Scholar 

  8. Kanwar YS, Farquhar MG (1980) Role of glycosaminoglycans in permeability of glomerular basement membrane. Fed Proc 39: 334–339

    Google Scholar 

  9. Parthasarathy N, Spiro RG (1981) Characterisation of the glycosaminoglycan component of the renal glomerular basement membrane and its relationship to the peptide portion. J Biol Chem 256: 507–513

    PubMed  Google Scholar 

  10. Bennett CM, Glassock RJ, Chang RLS, Deen WM, Robertson CR, Brenner BM (1976) Permselectivity of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using dextran sulfate. J Clin Invest 57: 1287–1294

    PubMed  Google Scholar 

  11. Robson AM, Giangiacomo J, Kienstra RA, Naqvi ST, Ingelfinger JR (1974) Normal glomerular permeability and its modification by minimal change nephrotic syndrome. J Clin Invest 54: 1190–1199

    PubMed  Google Scholar 

  12. Carrie BJ, Salyer WR, Myers BD (1981) Minimal change nephropathy; an electrochemical disorder of the glomerular membrane. Am J Med 70:262–268

    PubMed  Google Scholar 

  13. Vernier RL, Klein DJ, Sisson SP, Mahan JD, Oegema TR, Brown DM (1983) Heparan sulfate-rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome. N Engl J Med 309: 1001–1009

    PubMed  Google Scholar 

  14. Westberg NG, Michael AF (1973) Human glomerular basement membrane chemical composition in diabetes mellitus. Acta Med Scand 194: 39–47

    Google Scholar 

  15. Vehaskari VM, Root ER, Germuth FG, Robson AM (1982) Glomerular charge and urinary protein excretion: effects of systemic and intrarenal polycation infusion in the rat. Kidney Int 22: 127–135

    PubMed  Google Scholar 

  16. Rosenzweig LJ, Kanwar YS (1982) Removal of sulfated (heparan sulphate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to125I-bovine serum albumin. Lab Invest 47: 177–184

    PubMed  Google Scholar 

  17. Mahan JD, Vernier RL (1987) Congenital nephrotic syndrome. In: Holliday MA, Barratt TM, Vernier RL (eds) Pediatric nephrology, 2nd edn. Williams and Wilkins, Baltimore, pp 457–462

    Google Scholar 

  18. Westberg NG, Michael AF (1970) Human glomerular basement membrane preparation an composition. Biochemistry 9: 3837–3846

    PubMed  Google Scholar 

  19. Whiteman P (1973) The quantitative determination of glycosaminoglycans in urine with Alcian Blue 8GX. Biochem J 131: 351–357

    PubMed  Google Scholar 

  20. Kanwar YS, Farquhar MG (1979) Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the laminae rarae by cationic probes. J Cell Biol 81: 137–153

    PubMed  Google Scholar 

  21. Caulfield JP, Farquhar MG (1976) Distribution of anionic sites in glomerular basement membranes: their possible role in filtration and attachment. Proc Natl Acad Sci USA 73: 1646–1650

    PubMed  Google Scholar 

  22. Kanwar YS, Farquhar MG (1979) Presence of heparan sulphate in the glomerular basement membrane. Proc Natl Acad Sci USA 76: 1303–1307

    PubMed  Google Scholar 

  23. Kanwar YS, Linker A, Farquhar MG (1980) Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion. J Cell Biol 86: 688–693

    PubMed  Google Scholar 

  24. Kanwar YS, Rosenzweig LJ (1982) Clogging of the glomerular basement membrane. J Cell Biol 93: 489–494

    PubMed  Google Scholar 

  25. Mathews MB, Lozaityte I (1958) Sodium chondroitin sulphate-protein complexes of cartilage. 1. Molecular weight and shape. Arch Biochem Biophys 74: 158–174

    PubMed  Google Scholar 

  26. Kanwar YS, Hascall VC, Farquhar MG (1981) Partial characterization of newly synthesized proteoglycans isolated from the glomerular basement membrane. J Cell Biol 90: 527–532

    PubMed  Google Scholar 

  27. Reubsaet FA, Langeveld JP, Veerkamp JH (1985) Glycosaminoglycan content of glomerular and tubular basement membranes of various mammalian species. Biochem Biophys Acta 838: 144–150

    PubMed  Google Scholar 

  28. Parthasarathy N, Spiro RG (1982) Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes 31: 738–741

    PubMed  Google Scholar 

  29. Kanwar YS, Veis A, Kimuna JH, Jakubowski ML (1984) Characterisation of heparan sulphate proteoglycan of glomerular basement membrane. Proc Natl Acad Sci USA 81: 762–766

    PubMed  Google Scholar 

  30. Parthasarathy N (1985) Quantitative method for the determination of glycosaminoglycans from small quantities of glomerular basement membranes. Renal Physiol 8: 45–49

    PubMed  Google Scholar 

  31. Whiteman P (1973) The quantitative measurement of Alcian Blue glycosaminoglycan complexes. Biochem J 131: 343–350

    PubMed  Google Scholar 

  32. Wight TN (1980) Vessel proteoglycans and thrombogenesis. In: Spaet TH (ed) Progress in hemostasis and thrombosis, vol 5. Grune and Stratton, New York, pp 1–39

    Google Scholar 

  33. Lindahl U, Hook M (1978) Glycosaminoglycans and their binding to biological macromolecules. Annu Rev Biochem 47: 385–417

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatric Nephrology, Instite of Child Health, 30 Guilford Street, WC1N 1EH, London, UK

    Christiane Vermylen, Michael Levin & T. Martin Barratt

  2. Department of Clinical Biochemistry, Institute of Child Health, 30 Guilford Street, WC1N 1EH, London, UK

    Jean Mossman

Authors
  1. Christiane Vermylen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Levin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean Mossman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Martin Barratt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vermylen, C., Levin, M., Mossman, J. et al. Clomerular and urinary heparan sulphate in congenital nephrotic syndrome. Pediatr Nephrol 3, 122–129 (1989). https://doi.org/10.1007/BF00852891

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00852891

Key words

Search

Navigation